LPL Financial’s Mateon Therapeutics, Inc. MATN Stock Holding History
Bought
Maintained
Sold
Other funds holding MATN
LPL Financial's MATN Position: Q4 2016 in Review
LPL Financial sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 12,887 shares — an estimated $8K sold.
LPL Financial first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $9K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.
- LPL Financial reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
- LPL Financial sold 12,887 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $8K.
- LPL Financial first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
- LPL Financial's Mateon Therapeutics, Inc. position peaked at $9K in Q2 2016.
- 1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.
Based on LPL Financial's 13F filing for Q4 2016, filed 13 Feb 2017.